Role of Exosomes in Diagnosis, Prognostication, and Treatment of Pediatric Solid Tumors

Overview

Journal Mol Ther Oncol

Date 2025 Feb 3

PMID 39895692

Authors

Shaikh M Ghufran

Morgan L Brown

Elizabeth A Beierle

Affiliations

Soon will be listed here.

Abstract

Cancer is the second leading cause of death in children, and solid tumors make up 30% of childhood cancers. Molecular profiling of pediatric solid tumors allows a personalized approach to therapy, but this approach mostly relies on surgical biopsy, which is invasive and carries the risk of complications. Liquid biopsy serves as a reliable alternative and a minimally invasive tool for diagnosing, prognosticating, and residual disease monitoring in childhood cancers. This review outlines the potential of exosomes as informative liquid biopsies in pediatric solid tumors. Studies highlighting the potential applications and clinical utility of exosomes and their molecular constituents as prognosticators and therapies in common childhood solid tumors, including neuroblastoma, medulloblastoma, sarcoma, and hepatoblastoma, have been overviewed. We also discuss the limitations and technical challenges of utilizing exosomes for pediatric solid tumors.

References

Agnoletto C, Pignochino Y, Caruso C, Garofalo C . Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application. Int J Mol Sci. 2023; 24(6). PMC: 10048895. DOI: 10.3390/ijms24065159. View

Panachan J, Rojsirikulchai N, Pongsakul N, Khowawisetsut L, Pongphitcha P, Siriboonpiputtana T . Extracellular Vesicle-Based Method for Detecting Amplification Status of Pediatric Neuroblastoma. Cancers (Basel). 2022; 14(11). PMC: 9179557. DOI: 10.3390/cancers14112627. View

Tsuno H, Suematsu N, Sato T, Arito M, Matsui T, Iizuka N . Effects of methotrexate and salazosulfapyridine on protein profiles of exosomes derived from a human synovial sarcoma cell line of SW982. Proteomics Clin Appl. 2015; 10(2):164-71. DOI: 10.1002/prca.201500064. View

Wang J, Wu X, Gu X, Jiang X . Exosomal miR-1228 From Cancer-Associated Fibroblasts Promotes Cell Migration and Invasion of Osteosarcoma by Directly Targeting SCAI. Oncol Res. 2018; 27(9):979-986. PMC: 7848259. DOI: 10.3727/096504018X15336368805108. View

VENTURA S, Aryee D, Felicetti F, De Feo A, Mancarella C, Manara M . CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling. Oncogene. 2015; 35(30):3944-54. PMC: 4967355. DOI: 10.1038/onc.2015.463. View

Nie M, Huang D, Chen G, Zhao Y, Sun L . Bioadhesive Microcarriers Encapsulated with IL-27 High Expressive MSC Extracellular Vesicles for Inflammatory Bowel Disease Treatment. Adv Sci (Weinh). 2023; 10(32):e2303349. PMC: 10646269. DOI: 10.1002/advs.202303349. View

Liu W, Chen S, Liu B . Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr Surg Int. 2016; 32(11):1059-1065. DOI: 10.1007/s00383-016-3960-8. View

Ghamloush F, Ghayad S, Rammal G, Fahs A, Ayoub A, Merabi Z . The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486. Sci Rep. 2019; 9(1):14242. PMC: 6775163. DOI: 10.1038/s41598-019-50592-4. View

Lone S, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S . Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022; 21(1):79. PMC: 8932066. DOI: 10.1186/s12943-022-01543-7. View

10.

Rammal G, Fahs A, Kobeissy F, Mechref Y, Zhao J, Zhu R . Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling. J Proteome Res. 2019; 18(10):3567-3579. DOI: 10.1021/acs.jproteome.9b00157. View

11.

Huang M, Weiss W . Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013; 3(10):a014415. PMC: 3784814. DOI: 10.1101/cshperspect.a014415. View

12.

Challagundla K, Wise P, Neviani P, Chava H, Murtadha M, Xu T . Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015; 107(7). PMC: 4651042. DOI: 10.1093/jnci/djv135. View

13.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

14.

Esposti C, Iadarola B, Maestri S, Beltrami C, Lavezzari D, Morini M . Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells. Int J Mol Sci. 2021; 22(7). PMC: 8036333. DOI: 10.3390/ijms22073667. View

15.

Yokoo S, Fujiwara T, Yoshida A, Uotani K, Morita T, Kiyono M . Liquid Biopsy Targeting Monocarboxylate Transporter 1 on the Surface Membrane of Tumor-Derived Extracellular Vesicles from Synovial Sarcoma. Cancers (Basel). 2021; 13(8). PMC: 8069269. DOI: 10.3390/cancers13081823. View

16.

Abd Elmageed Z, Yang Y, Thomas R, Ranjan M, Mondal D, Moroz K . Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells. 2014; 32(4):983-97. PMC: 4184251. DOI: 10.1002/stem.1619. View

17.

Ma J, Xu M, Yin M, Hong J, Chen H, Gao Y . Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma. Front Oncol. 2019; 9:459. PMC: 6582313. DOI: 10.3389/fonc.2019.00459. View

18.

Northcott P, Robinson G, Kratz C, Mabbott D, Pomeroy S, Clifford S . Medulloblastoma. Nat Rev Dis Primers. 2019; 5(1):11. DOI: 10.1038/s41572-019-0063-6. View

19.

Zhou Y, Du T, Yang C, Li T, Li X, Liu W . Extracellular vesicles encapsulated with caspase-1 inhibitor ameliorate experimental autoimmune myasthenia gravis through targeting macrophages. J Control Release. 2023; 364:458-472. DOI: 10.1016/j.jconrel.2023.11.006. View

20.

Chen Y, Takita J, Choi Y, Kato M, Ohira M, Sanada M . Oncogenic mutations of ALK kinase in neuroblastoma. Nature. 2008; 455(7215):971-4. DOI: 10.1038/nature07399. View